Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding

2007 ◽  
Vol 35 (4) ◽  
pp. 721-723 ◽  
Author(s):  
D.F. Mierke ◽  
L. Mao ◽  
M. Pellegrini ◽  
A. Piserchio ◽  
J. Plati ◽  
...  

Over the years, the association of peptide ligands to Family B GPCRs (G-protein coupled receptors) has been characterized by a number of experimental and theoretical techniques. For the PTH (parathyroid hormone) ligand–receptor system, important insight has been provided by photoaffinity labelling experiments and the elucidation of direct contact points between ligand and receptor. Our research has focused on the structural elucidation of the receptor domains shown to be involved in the binding of PTH. Employing a combination of carefully designed receptor domains, solution-state NMR carried out in the presence of membrane mimetics and extensive computer simulations, we have obtained a well-resolved model of the ligand–receptor complex for PTH. Here, we review the development of this model and highlight some inherent limitations of the methods employed and their consequences on interpretation of the ligand–receptor model.

FEBS Open Bio ◽  
2015 ◽  
Vol 6 (1) ◽  
pp. 90-102 ◽  
Author(s):  
Lisa Joedicke ◽  
Raphael Trenker ◽  
Julian D. Langer ◽  
Hartmut Michel ◽  
Julia Preu

2015 ◽  
Vol 51 (28) ◽  
pp. 6157-6160 ◽  
Author(s):  
Yuting Liu ◽  
Yingying Cai ◽  
Wei Liu ◽  
Xiao-Han Li ◽  
Elizabeth Rhoades ◽  
...  

Design and characterization of triblock peptide–linker–lipid constructs for targeting family B G protein-couple receptors with improved bioactivity and biostability.


2021 ◽  
Vol 118 (45) ◽  
pp. e2107363118
Author(s):  
Ming-Wei Wang ◽  
Zhao Yang ◽  
Xu Chen ◽  
Shu-Hua Zhou ◽  
Ge-Lin Huang ◽  
...  

Inflammation in the epididymis and testis contributes significantly to male infertility. Alternative therapeutic avenues treating epididymitis and orchitis are expected since current therapies using antibiotics have limitations associated to side effects and are commonly ineffective for inflammation due to nonbacterial causes. Here, we demonstrated that type 1 parathyroid hormone receptor (PTH1R) and its endogenous agonists, parathyroid hormone (PTH) and PTH-related protein (PTHrP), were mainly expressed in the Leydig cells of testis as well as epididymal epithelial cells. Screening the secretin family G protein–coupled receptor identified that PTH1R in the epididymis and testis was down-regulated in mumps virus (MuV)- or lipopolysaccharide (LPS)-induced inflammation. Remarkably, activation of PTH1R by abaloparatide (ABL), a Food and Drug Administration–approved treatment for postmenopausal osteoporosis, alleviated MuV- or LPS-induced inflammatory responses in both testis and epididymis and significantly improved sperm functions in both mouse model and human samples. The anti-inflammatory effects of ABL were shown to be regulated mainly through the Gq and β-arrestin-1 pathway downstream of PTH1R as supported by the application of ABL in Gnaq± and Arrb1−/− mouse models. Taken together, our results identified an important immunoregulatory role for PTH1R signaling in the epididymis and testis. Targeting to PTH1R might have a therapeutic effect for the treatment of epididymitis and orchitis or other inflammatory disease in the male reproductive system.


Physiology ◽  
1998 ◽  
Vol 13 (5) ◽  
pp. 231-240 ◽  
Author(s):  
Stephan K. Böhm ◽  
Karen McConalogue ◽  
Wuyi Kong ◽  
Nigel W. Bunnett

Although proteases are traditionally viewed as degradative enzymes, characterization of a family of G protein-coupled receptors that are activated by proteolysis reveals a new role. Certain proteases function as signaling molecules that specifically regulate cells by cleaving and activating a family of proteinase-activated receptors.


Sign in / Sign up

Export Citation Format

Share Document